IGF1R and cancer: In particular, insulin-like growth factor-1 receptor (IGF1R) is thought to play a key role in the acquisition of cancer resistance to trastuzumab and other targeted pharmaceuticals[10,11]; however, little is currently known regarding the regulation of IGF1R in these cells during the development of resistance to trastuzumab.